Rhythm Biosciences (RHY.AX) Stock Price

Rhythm Biosciences Price

ASX·CLOSED
0.08AUD-0.0040 (-4.82 %)
Market closed

Over the last 7 years Rhythm Biosciences grew revenue by 75.6% annually, reaching 3.33 M AUD. For Rhythm Biosciences, the net margin of -115.1% is up versus -47,230.0% a few years ago. The stock trades about 5% above its 52-week low.

Rhythm Biosciences stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Rhythm Biosciences over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Rhythm Biosciences stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Rhythm Biosciences's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Rhythm Biosciences Stock Price History
DateRhythm Biosciences Price
8/13/20260.08 AUD
8/12/20260.09 AUD
8/11/20260.09 AUD
8/10/20260.09 AUD
8/7/20260.10 AUD
8/6/20260.09 AUD
8/5/20260.09 AUD
8/4/20260.08 AUD
8/3/20260.08 AUD
7/31/20260.08 AUD
7/30/20260.08 AUD
7/29/20260.08 AUD
7/28/20260.08 AUD
7/27/20260.08 AUD
7/24/20260.09 AUD
7/23/20260.09 AUD
7/22/20260.08 AUD
7/21/20260.09 AUD
7/20/20260.09 AUD
7/17/20260.09 AUD
7/16/20260.09 AUD
7/15/20260.09 AUD
7/14/20260.09 AUD
7/13/20260.09 AUD
7/10/20260.09 AUD
7/9/20260.09 AUD
7/8/20260.09 AUD
7/7/20260.09 AUD
7/6/20260.09 AUD
7/3/20260.09 AUD
7/2/20260.10 AUD
7/1/20260.10 AUD
6/30/20260.09 AUD
6/29/20260.09 AUD
6/26/20260.10 AUD
6/25/20260.09 AUD
6/24/20260.09 AUD
6/23/20260.10 AUD
6/22/20260.10 AUD
6/19/20260.11 AUD
6/18/20260.12 AUD
6/17/20260.12 AUD
6/16/20260.11 AUD
6/15/20260.12 AUD
6/12/20260.11 AUD
6/11/20260.11 AUD
6/10/20260.11 AUD
6/9/20260.12 AUD
6/5/20260.10 AUD
6/4/20260.11 AUD
6/3/20260.12 AUD
6/2/20260.11 AUD
6/1/20260.10 AUD
5/29/20260.12 AUD
5/28/20260.13 AUD
5/27/20260.13 AUD
5/26/20260.13 AUD
5/25/20260.13 AUD
5/22/20260.12 AUD
5/21/20260.13 AUD
5/20/20260.13 AUD
5/19/20260.14 AUD
5/18/20260.13 AUD
5/15/20260.14 AUD
5/14/20260.14 AUD
5/13/20260.13 AUD
5/12/20260.14 AUD
5/11/20260.14 AUD
5/8/20260.14 AUD
5/7/20260.15 AUD
5/6/20260.14 AUD
5/5/20260.14 AUD
5/4/20260.14 AUD
5/1/20260.14 AUD
4/30/20260.14 AUD
4/29/20260.14 AUD
4/28/20260.15 AUD
4/27/20260.17 AUD
4/24/20260.17 AUD
4/23/20260.17 AUD
4/22/20260.17 AUD
4/21/20260.17 AUD
4/20/20260.17 AUD
4/17/20260.19 AUD
4/16/20260.19 AUD
4/15/20260.19 AUD
4/14/20260.19 AUD
4/13/20260.19 AUD
4/10/20260.19 AUD
4/9/20260.19 AUD
4/8/20260.19 AUD
4/7/20260.18 AUD
4/2/20260.19 AUD
4/1/20260.19 AUD
3/31/20260.18 AUD
3/30/20260.19 AUD
3/27/20260.19 AUD
3/26/20260.19 AUD
3/25/20260.20 AUD
3/24/20260.19 AUD
3/23/20260.19 AUD
3/20/20260.20 AUD
3/19/20260.22 AUD
3/18/20260.23 AUD
3/17/20260.21 AUD
3/16/20260.22 AUD
3/13/20260.21 AUD
3/12/20260.20 AUD
3/11/20260.22 AUD
3/10/20260.20 AUD
3/9/20260.20 AUD
3/6/20260.19 AUD
3/5/20260.18 AUD
3/4/20260.18 AUD
3/3/20260.19 AUD
3/2/20260.20 AUD
2/27/20260.22 AUD
2/26/20260.22 AUD
2/25/20260.22 AUD
2/24/20260.20 AUD
2/23/20260.20 AUD
2/20/20260.20 AUD
2/19/20260.22 AUD
2/18/20260.22 AUD
2/17/20260.21 AUD
2/16/20260.20 AUD
2/13/20260.21 AUD
2/12/20260.24 AUD
2/11/20260.25 AUD
2/10/20260.22 AUD
2/9/20260.25 AUD
2/6/20260.25 AUD
2/5/20260.23 AUD
2/4/20260.17 AUD
2/3/20260.19 AUD
2/2/20260.15 AUD
1/30/20260.14 AUD
1/29/20260.17 AUD
1/28/20260.15 AUD
1/27/20260.14 AUD
1/23/20260.15 AUD
1/22/20260.16 AUD
1/21/20260.16 AUD
1/20/20260.15 AUD
1/19/20260.15 AUD
1/16/20260.16 AUD
1/15/20260.16 AUD
1/14/20260.14 AUD
1/13/20260.12 AUD
1/12/20260.12 AUD
1/9/20260.13 AUD
1/8/20260.12 AUD
1/7/20260.10 AUD
1/6/20260.12 AUD
1/5/20260.12 AUD
1/2/20260.13 AUD
12/31/20250.14 AUD
12/30/20250.14 AUD
12/29/20250.12 AUD
12/24/20250.12 AUD
12/23/20250.12 AUD
12/22/20250.11 AUD
12/19/20250.10 AUD
12/18/20250.10 AUD
12/17/20250.09 AUD
12/16/20250.09 AUD
12/15/20250.09 AUD
12/12/20250.10 AUD
12/11/20250.08 AUD
12/10/20250.08 AUD
12/9/20250.08 AUD
12/8/20250.08 AUD
12/5/20250.08 AUD
12/4/20250.08 AUD
12/3/20250.08 AUD
12/2/20250.09 AUD
12/1/20250.09 AUD
11/28/20250.09 AUD
11/27/20250.09 AUD
11/26/20250.08 AUD
11/25/20250.09 AUD
11/24/20250.09 AUD
11/21/20250.09 AUD
11/20/20250.09 AUD
11/19/20250.09 AUD
11/18/20250.09 AUD
11/17/20250.08 AUD
11/14/20250.09 AUD
11/13/20250.09 AUD
11/12/20250.09 AUD
11/11/20250.09 AUD
11/10/20250.08 AUD
11/7/20250.09 AUD
11/6/20250.09 AUD
11/5/20250.08 AUD
11/4/20250.09 AUD
11/3/20250.09 AUD
10/31/20250.09 AUD
10/30/20250.10 AUD
10/29/20250.09 AUD
10/28/20250.10 AUD
10/27/20250.09 AUD
10/24/20250.09 AUD
10/23/20250.09 AUD
10/22/20250.09 AUD
10/21/20250.09 AUD
10/20/20250.10 AUD
10/17/20250.09 AUD
10/16/20250.09 AUD
10/15/20250.10 AUD
10/14/20250.10 AUD
10/13/20250.10 AUD
10/10/20250.10 AUD
10/9/20250.09 AUD
10/8/20250.09 AUD
10/7/20250.09 AUD
10/6/20250.09 AUD
10/3/20250.09 AUD
10/2/20250.09 AUD
10/1/20250.09 AUD
9/30/20250.08 AUD
9/29/20250.09 AUD
9/26/20250.09 AUD
9/25/20250.09 AUD
9/24/20250.09 AUD
9/23/20250.09 AUD
9/22/20250.09 AUD
9/19/20250.09 AUD
9/18/20250.09 AUD
9/17/20250.09 AUD
9/16/20250.09 AUD
9/15/20250.09 AUD
9/12/20250.09 AUD
9/11/20250.09 AUD
9/10/20250.08 AUD
9/9/20250.09 AUD
9/8/20250.09 AUD
9/5/20250.08 AUD
9/4/20250.08 AUD
9/3/20250.09 AUD
9/2/20250.09 AUD
9/1/20250.09 AUD
8/29/20250.10 AUD
8/28/20250.10 AUD
8/27/20250.10 AUD
8/26/20250.10 AUD
8/25/20250.10 AUD
8/22/20250.09 AUD
8/21/20250.11 AUD
8/20/20250.11 AUD
8/19/20250.11 AUD
8/18/20250.11 AUD
8/15/20250.10 AUD
Access this data via the Eulerpool API
Get Free API Key

Rhythm Biosciences Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
64,500.00 AUD
-1.56 M AUD
-1.75 M AUD
Jan 1, 2019
141,100.00 AUD
-3.57 M AUD
-2.55 M AUD
Jan 1, 2020
46,300.00 AUD
-4.12 M AUD
-4.02 M AUD
Jan 1, 2021
14,000.00 AUD
-7.72 M AUD
-6.61 M AUD
Jan 1, 2022
25,000.00 AUD
-11.22 M AUD
-8.79 M AUD
Jan 1, 2023
3.31 M AUD
-8.23 M AUD
-8.22 M AUD
Jan 1, 2024
1.74 M AUD
-3.81 M AUD
-6.86 M AUD
Jan 1, 2025
3.33 M AUD
-3.60 M AUD
-3.83 M AUD

Rhythm Biosciences Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 14, 2026, 4:30 AM
 
REVENUEM AUD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM AUD
EBITM AUD
EBIT MARGIN%
NET INCOMEM AUD
NET INCOME GROWTH%
SHARESM
201720182019202020212022202320242025
––––––3.001.003.00
–––––––-66.67200.00
––––––66.67200.0066.67
2.002.00-1.00-1.00-2.002.002.002.002.00
–-1.00-3.00-4.00-7.00-11.00-8.00-3.00-3.00
––––––-266.67-300.00-100.00
–-1.00-2.00-4.00-6.00-8.00-8.00-6.00-3.00
––100.00100.0050.0033.33–-25.00-50.00
115.4689.30115.46101.02189.70214.45221.55228.30269.25
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Rhythm Biosciences generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Rhythm Biosciences retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Rhythm Biosciences's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Rhythm Biosciences has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Rhythm Biosciences's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Rhythm Biosciences stock margins

The Rhythm Biosciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Rhythm Biosciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Rhythm Biosciences.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
-1,113.95 %
-2,425.12 %
-2,718.60 %
Jan 1, 2019
-1,046.70 %
-2,532.81 %
-1,804.54 %
Jan 1, 2020
-2,919.01 %
-8,888.12 %
-8,688.98 %
Jan 1, 2021
-15,541.43 %
-55,139.28 %
-47,230.00 %
Jan 1, 2022
-689.60 %
-44,883.60 %
-35,174.00 %
Jan 1, 2023
83.23 %
-248.82 %
-248.36 %
Jan 1, 2024
-51.41 %
-218.44 %
-393.53 %
Jan 1, 2025
-10.44 %
-108.12 %
-115.15 %

Rhythm Biosciences Stock Revenue, EBIT, Earnings per Share

The Rhythm Biosciences earnings per share therefore indicates how much revenue Rhythm Biosciences has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
0.00 AUD
-0.02 AUD
-0.02 AUD
Jan 1, 2019
0.00 AUD
-0.03 AUD
-0.02 AUD
Jan 1, 2020
0.00 AUD
-0.04 AUD
-0.04 AUD
Jan 1, 2021
0.00 AUD
-0.04 AUD
-0.03 AUD
Jan 1, 2022
0.00 AUD
-0.05 AUD
-0.04 AUD
Jan 1, 2023
0.01 AUD
-0.04 AUD
-0.04 AUD
Jan 1, 2024
0.01 AUD
-0.02 AUD
-0.03 AUD
Jan 1, 2025
0.01 AUD
-0.01 AUD
-0.01 AUD

Rhythm Biosciences business model & stock analysis

Rhythm Biosciences Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Rhythm Biosciences historical P/E ratio, EBIT multiple, and P/S ratio

Rhythm Biosciences annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Rhythm Biosciences shares outstanding

The number of shares of Rhythm Biosciences was 269.25 M in 2025. This indicates how many shares Rhythm Biosciences is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
89.30 M Stocks
Jan 1, 2019
115.46 M Stocks
Jan 1, 2020
101.02 M Stocks
Jan 1, 2021
189.70 M Stocks
Jan 1, 2022
214.45 M Stocks
Jan 1, 2023
221.55 M Stocks
Jan 1, 2024
228.30 M Stocks
Jan 1, 2025
269.25 M Stocks
Price targets and forecasts for Rhythm Biosciences are not yet available.

Rhythm Biosciences shareholder structure

% Name
6.85382%
Catapult Investors Pty. Ltd.
Catapult Investors Pty. Ltd.
4.23971%
Newfound Investments Pty Ltd
Newfound Investments Pty Ltd
1.42798%
Atkins (David)
Atkins (David)
0.31337%
Smith (Gavin Fox)
Smith (Gavin Fox)
0.13720%
MacLeman (Sue)
MacLeman (Sue)
0.00000%
Buttula (Otto Leslie Steven)
Buttula (Otto Leslie Steven)

Rhythm Biosciences Executives and Management Board

7 members · 29 % women

Management

DA

Mr. David Atkins

Chief Executive Officer, Managing Director, Director · since 2024

–
TP

Mr. Todd Perkinson

Chief Financial Officer

–
AS

Ms. Andrea Steele

General Counsel, Joint Company Secretary

–
GC

Mr. Guy Carisbrooke

Financial Controller

–
ED

Ms. Elena Deak

Chief Commercial Officer

–
JB

Mr. James Barrie

Joint Company Secretary

–

Board of Directors

GF

Mr. Gavin Fox-Smith

Chairman of the Board · since 2024

–

Frequently asked questions about Rhythm Biosciences

Converted at the current exchange rate, the Rhythm Biosciences share trades at 0.05 EUR (0.08 AUD).

The Rhythm Biosciences share (RHY.AX) is listed on 2 stock exchanges, including: Frankfurt (0RY.F), ASX (RHY.AX).

No history available for Rhythm Biosciences.

The revenue cannot currently be calculated for Rhythm Biosciences.

The profit cannot currently be calculated for Rhythm Biosciences.

The P/E ratio cannot be calculated for Rhythm Biosciences at the moment.

The P/S cannot be calculated for Rhythm Biosciences currently.

The Eulerpool Quality Score for Rhythm Biosciences is 3/10.

The ISIN of Rhythm Biosciences is AU000000RHY2. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Rhythm Biosciences is A2H8M4. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Rhythm Biosciences is RHY.AX. The ticker symbol is used to trade Rhythm Biosciences shares on the stock exchange.

Rhythm Biosciences paid dividends every year for the past 0 years.

Rhythm Biosciences is assigned to the 'Health' sector.

The dividends of Rhythm Biosciences are distributed in AUD.

All fundamentals and in-depth analysis of Rhythm Biosciences

Our stock analysis for Rhythm Biosciences stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rhythm Biosciences. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Rhythm Biosciences Stock
Rhythm Biosciences Revenue→
Rhythm Biosciences Stock
Rhythm Biosciences Net Income→
Rhythm Biosciences Stock
Rhythm Biosciences P/E→
Rhythm Biosciences Stock
Rhythm Biosciences P/S→
Rhythm Biosciences Stock
Rhythm Biosciences EBIT→
Rhythm Biosciences Stock
Rhythm Biosciences Dividend→
Rhythm Biosciences Stock
Rhythm Biosciences Directors Dealings→
Rhythm Biosciences Stock
Rhythm Biosciences Stocks→
Rhythm Biosciences Stock
Rhythm Biosciences Market capitalization→
Rhythm Biosciences Stock
Rhythm Biosciences Debt→
Rhythm Biosciences Stock
Rhythm Biosciences Liabilities→
Rhythm Biosciences Stock
Rhythm Biosciences Equity→
Rhythm Biosciences Stock
Rhythm Biosciences AAQS→
Rhythm Biosciences Stock
Rhythm Biosciences Employees→
Rhythm Biosciences Stock
Rhythm Biosciences ROE→
Rhythm Biosciences Stock
Rhythm Biosciences ROA→
Rhythm Biosciences Stock
Rhythm Biosciences ROCE→
Rhythm Biosciences Stock
Rhythm Biosciences News→
Rhythm Biosciences Stock
Rhythm Biosciences Analyst Price Targets→

Health Stocks

Rhythm PharmaceuticalsRhoen KlinikumRibomicRezoluteRichter Gedeon Vegyeszeti Gyar NyrtReyon Pharmaceutical CoRici Healthcare HoldingsRevvityRigel PharmaceuticalsRevolution MedicinesRion CoRevive TherapeuticsAll Stocks A–Z →